03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Cabazitaxel Ever Pharma : | |
Type | Medicine Authorised |
Originator | Jevtana |
Agent | Codipha |
Distributor | Codipha |
Laboratory | Ever Neuro Pharma |
Responsible Party | Ever Valinject GmbH |
Origin | Austria |
Manufacturer | Ever Pharma Jena GmbH |
Origin | Germany |
ATC | L01CD04 |
Cabazitaxel Ever Pharma :
Cabazitaxel Ever Pharma :
Cabazitaxel Ever Pharma :
Cabazitaxel Ever Pharma :
Cabazitaxel Ever Pharma :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal distension | Common |
Abdominal pain | Very Common |
Abdominal pain upper | Common |
Acute kidney injury | Common |
Alopecia | Very Common |
ALT increased | Not known |
Anaemia | Very Common |
Anxiety | Common |
Arthralgia (Pain joint) (Joint ache) | Very Common |
AST increased | Common |
Asthenia | Very Common |
Atrial fibrillation | Common |
Back pain | Very Common |
Blood bilirubin increased | Not known |
Candidiasis (Candida infection) | Common |
Cardiac arrest | Not known |
Cardiac failure | Not known |
Cellulitis | Common |
Chest pain | Common |
Chills | Common |
Colitis | Not known |
Confusional state | Common |
Conjunctivitis | Common |
Constipation | Very Common |
Cough | Very Common |
Cystitis | Common |
Decreased appetite | Very Common |
Deep vein thrombosis | Common |
Dehydration | Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Common |
Dry mouth (Xerostomia) | Common |
Dry skin | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dyspepsia | Common |
Dyspnoea (dyspnea) | Very Common |
Dysuria (Micturition painful) | Common |
Enterocolitis | Not known |
Erythema | Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Flank pain | Common |
Flushing | Common |
Gastritis | Not known |
Gastroduodenal haemorrhage | Not known |
Gastrointestinal perforation | Not known |
Gastrooesophageal reflux disease | Common |
Haematuria (Hematuria) | Very Common |
Haemorrhoids | Common |
Headache | Common |
Herpes zoster | Common |
Hot flush | Common |
Hydronephrosis | Common |
Hyperglycaemia | Common |
Hypersensitivity | Common |
Hypertension | Common |
Hypoesthesia | Common |
Hypokalaemia | Common |
Hypotension | Common |
Ileus | Not known |
Influenza | Common |
Intestinal obstruction | Not known |
Lacrimation increased (Epiphora) | Common |
Lethargy | Common |
Leucopenia (Leukopenia) | Very Common |
Malaise | Common |
Mucosal inflammation | Common |
Muscle spasms | Common |
Musculoskeletal chest pain | Common |
Myalgia | Common |
Nausea | Very Common |
Neuropathy peripheral | Common |
Neutropenia | Very Common |
Neutropenic colitis | Not known |
Neutropenic infection | Not known |
Neutropenic sepsis | Not known |
Oedema | Common |
Oedema peripheral | Common |
Oropharyngeal pain | Common |
Orthostatic hypotension | Common |
Pain | Common |
Pain in extremity (Pain in limb) | Common |
Paraesthesia (paresthesia) | Common |
Pelvic pain | Common |
Peripheral sensory neuropathy | Common |
Pneumonia | Common |
Pollakiuria (Urinary frequency) | Common |
Pyrexia | Very Common |
Rectal haemorrhage | Common |
Renal colic | Common |
Renal failure | Common |
Sciatica | Common |
Sepsis (Systemic infection) (Sepsis state) | Common |
Septic shock | Common |
Tachycardia | Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Tinnitus | Common |
Transaminases increased | Common |
Upper respiratory tract infection | Common |
Ureteric obstruction | Common |
Urinary incontinence | Common |
Urinary retention | Common |
Urinary tract infection | Common |
Ventricular fibrillation | Not known |
Vertigo | Common |
Vomiting | Very Common |
Weight decreased (Weight loss) | Common |
Cabazitaxel Ever Pharma :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
Different Units By MoH Code
Cabazitaxel Ever Pharma MoH 10672 :
Form | Concentrate for solution for infusion |
Packaging | Bottle |
Package Size | 1x6ml |
Strength | 60mg |
Storage Condition | <30°C Do not refrigerate |
Public Price | 3972131 L.L. |
Stratum | E2 |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 60621/1 |
Submission date | 06/05/2021 |
Registration Year | 28/05/2021 |
Price Comparison
● Country: | Lebanon | |
● Form: | Concentrate for solution for infusion | |
● Package Size: | 1x6ml | |
● Public Price: | 3972131 LBP | ( 3,972,131.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 3972131 LBP | ( 3,972,131.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | France |
● Package Size: | 1x6ml |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
● Country: | Finland |
● Package Size: | 1x6ml |
● Reference: | Kela |
● Pricing Date: | 22/04/2021 |
● Type: | Medicine Non Marketed |
Note
● Cost/Unit: | 3972131 LBP | ( 3,972,131.00 LBP ) |
● Cost/Day: | 3972131 LBP | ( 3,972,131.00 LBP ) |
● Cost/Month: | 2979098,25 LBP | ( 2,979,098.00 LBP ) |
You have to register to view this info
Drop File